Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase. - Wikidata - awgldk - TriplyDB

Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase.

Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase.

http://www.wikidata.org/entity/Q37173117

about

Survival of encapsulated islets: More than a membrane story Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats Therapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial Hypertension Alpha-1 antitrypsin supplementation improves alveolar macrophages efferocytosis and phagocytosis following cigarette smoke exposure.Inflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients 'on' or 'off' augmentation therapy.α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes.α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.Therapy with plasma purified alpha1-antitrypsin (Prolastin®) induces time-dependent changes in plasma levels of MMP-9 and MPO.Design of a multi-center immunophenotyping analysis of peripheral blood, sputum and bronchoalveolar lavage fluid in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)Simultaneous Pathoproteomic Evaluation of the Dystrophin-Glycoprotein Complex and Secondary Changes in the mdx-4cv Mouse Model of Duchenne Muscular Dystrophy Comparative analysis of morphological and molecular motifs in bronchiolitis obliterans and alveolar fibroelastosis after lung and stem cell transplantation.Human Alpha-1-Antitrypsin (hAAT) therapy reduces renal dysfunction and acute tubular necrosis in a murine model of bilateral kidney ischemia-reperfusion injury.Alpha-1-antitrypsin suppresses oxidative stress in preeclampsia by inhibiting the p38MAPK signaling pathway: An in vivo and in vitro study.Plasma α1-antitrypsin: a neglected predictor of angiographic severity in patients with stable angina pectoris Neonatal NET-inhibitory factor and related peptides inhibit neutrophil extracellular trap formation.Exploration of α1-antitrypsin treatment protocol for islet transplantation: dosing plan and route of administration.Understanding Lung Deposition of Alpha-1 Antitrypsin in Acute Experimental Mouse Lung Injury Model Using Fluorescence Microscopy Concurrent Label-Free Mass Spectrometric Analysis of Dystrophin Isoform Dp427 and the Myofibrosis Marker Collagen in Crude Extracts from mdx-4cv Skeletal Muscles.Mysteries of α1-antitrypsin deficiency: emerging therapeutic strategies for a challenging disease.The multiple facets of alpha-1-antitrypsin.The Natural History of Lung Function in Severe Deficiency of Alpha-1 Antitrypsin Following Orthotopic Liver Transplantation: A Case Report.Neutrophilic panniculitis associated with alpha-1-antitrypsin deficiency: an update.Therapeutics: Gene Therapy for Alpha-1 Antitrypsin Deficiency.Treatment options for moderate-to-very severe chronic obstructive pulmonary disease.Therapeutic compositions and uses of alpha1-antitrypsin: a patent review (2012 - 2015).Neutrophil Fates in Bronchiectasis and Alpha-1 Antitrypsin Deficiency.Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.α-Linoleic acid enhances the capacity of α-1 antitrypsin to inhibit lipopolysaccharide-induced IL-1β in human blood neutrophils Alpha-1 Antitrypsin Investigations Using Animal Models of Emphysema Novel RNA-binding activity of NQO1 promotes SERPINA1 mRNA translation.Acute phase protein α1-antitrypsin reduces the bacterial burden in mice by selective modulation of innate cell responses.Alpha-1 antitrypsin augmentation therapy decreases miR-199a-5p, miR-598 and miR-320a expression in monocytes via inhibition of NFκB.Alpha-1 antitrypsin and granulocyte colony-stimulating factor as serum biomarkers of disease severity in ulcerative colitis.[Aberrant reparative tissue remodeling: histopathology and molecular pathology].α-1-antitrypsin inhibits acute liver failure in mice.Evaluation of Alpha-1 Antitrypsin Levels and SERPINA1 Gene Polymorphisms in Sickle Cell Disease.Toxoplasma gondii serine-protease inhibitor-1: A new adjuvant candidate for asthma therapy.Aged interleukin-10tm1Cgn chronically inflamed mice have substantially reduced fat mass, metabolic rate, and adipokines.Assembly of bioactive multilayered nanocoatings on pancreatic islet cells: incorporation of α1-antitrypsin into the coatings.Therapeutics: Alpha-1 Antitrypsin Augmentation Therapy.

P2860

Q26751467-C8D06BDF-96BD-44F9-B5F7-49E27AA64E24 Q26858837-6482EEA7-A249-4732-A1F3-9985916FA592 Q28553086-4F44985F-B98A-420A-9274-AAC36EAD0FFF Q33610265-F93735AA-CEFF-47D3-AF95-6ED566A69827 Q33880491-1C3FDA6C-2636-4C8A-9301-A2B8AF9621F8 Q33999020-3EF0E0A8-8841-4B8E-BB1F-2B6A06F14FA0 Q34428735-62C98F68-DFCE-46F7-9165-4D05F05C062C Q35031693-136A6C5E-0BEE-4691-9A8F-1538A29D96F4 Q35041299-58D29B1E-8B09-4CE9-A6E5-41228BB70817 Q35837856-C0FE5466-0D81-4735-BFDC-8B32C797BF8A Q36264358-6B8C2E1A-74FB-4CE0-8B04-3BC84D31A135 Q36290085-7C85DEC7-9DBD-410D-8539-94CBA2868729 Q36328239-93E466A5-53D3-4669-8EEC-EFBAD18E784A Q36804760-8D6F2BA5-94DF-4BBE-B76E-41CB121FD885 Q37395688-AA42105D-0F6C-41C2-A483-D2EE38E2CF67 Q37427900-07B0462E-E29B-48B9-931D-123ED452E62A Q37516657-F50E1AE1-543D-46AD-B879-37AB15190DEF Q37566483-911F839A-54BA-4630-A7E4-1AE2170CEE01 Q37682374-A35E86B9-0C41-4720-9375-847ABC6E99D2 Q38553419-8A326785-0697-4415-A50B-695F5BC991A2 Q38604663-37F5ACF4-EB28-44C0-8C13-FBA45ED8F3A4 Q38643507-A7A92387-1F39-47D3-ABA9-F05BF5C74F02 Q38650541-F67C8FDB-67A2-45CD-949A-297AC7D1F0DA Q38740756-079DABB2-CB32-43F5-9DEF-00CC6A703885 Q38769762-869E01E2-8C1B-4187-BE99-A64BE44DC59E Q38875787-833314F9-9DC5-438B-A282-485C0A2B5272 Q38937862-D709AAFC-6ECA-4302-9867-A32F65649347 Q39565971-8B65CAF5-079C-427E-90A4-17C26D994495 Q41429852-7E5C3B15-FE61-45AF-BE15-E47B0EBBC517 Q41642043-ACBD4B72-EF06-40F8-BDB2-12041DD3FD9C Q41666547-BBFBA82A-AAA7-4664-B5D6-C6E000F7B76A Q42924805-854E1B57-15B6-4C4F-9638-5E90375BFF2B Q43551236-B6DF576C-6FA5-4EBE-A0EC-31F525CDFB37 Q44835646-E0AE9535-1256-401B-A588-BD5D3F50F163 Q46902299-A8DF117F-995E-4290-82F8-E84ED8C03C33 Q47108958-7D9F216B-19B0-4A1E-9D9E-1AAFC0EFAC87 Q47140820-154B4222-8BEE-4B3A-B8C7-C16E11E5D06D Q47561544-7DC11764-E884-49ED-9451-795A0F07437E Q47567662-A36C487C-B3E4-4078-A9AF-401CB81566CF Q47703811-AEF3A911-4C6F-4144-871F-0A971803447A

P2860

Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase.

http://www.wikidata.org/entity/Q37173117

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Anti-inflammatory and immunomo ...... ithout inhibition of elastase.

@en

Anti-inflammatory and immunomo ...... ithout inhibition of elastase.

@nl

type

label

Anti-inflammatory and immunomo ...... ithout inhibition of elastase.

@en

Anti-inflammatory and immunomo ...... ithout inhibition of elastase.

@nl

prefLabel

Anti-inflammatory and immunomo ...... ithout inhibition of elastase.

@en

Anti-inflammatory and immunomo ...... ithout inhibition of elastase.

@nl

P1433

Q37173117-1CAA4E9D-6DC4-4D3A-A05D-71F622BB4CB0

P1476

Q37173117-4AECF575-190D-4329-8B89-9982E50C3CEF

P2093

Q37173117-0180E3BD-97A2-41A7-8A2F-027F7D02BF6D

Q37173117-0252D956-6B17-46B2-8210-93E0201680AD

Q37173117-12F11C1D-DF5A-459F-9897-8393EB841D1A

Q37173117-21FDB0FA-0008-4F88-A0C4-38C597B26191

Q37173117-35350322-D096-4726-9124-076CE47CF846

Q37173117-41C220B1-6597-4A38-83D6-4503BD79A2E3

Q37173117-643F62C2-90D2-4940-9315-614D409198DD

Q37173117-8126D685-F62F-48AB-91B5-E9CB1ECD3F6B

Q37173117-9C237FFE-2EAF-46DB-8651-BFFB8361B606

Q37173117-BB0F28B7-BBB6-48C0-AC19-A058F7AA7DA8

P2860

Q37173117-05F082D8-FFEA-4492-88B3-0EE9D322C79D

Q37173117-05F4C691-D86A-4D7C-B4FC-B54D17B8CED6

Q37173117-0D564006-2663-467E-99A9-65AF8C3DA10B

Q37173117-0F77DE0D-752E-4A7E-B109-FF10396D4569

Q37173117-1033121B-6675-4EB7-B911-B7E64155671E

Q37173117-1304932F-D03D-4D19-94D0-68495FC6A1C2

Q37173117-16CFA7D0-3FDD-4F45-8686-24F2F07D3109

Q37173117-19D76ABE-0B9A-4058-BB0F-2AC24B2236EE

Q37173117-1C6FB264-401B-4205-9A27-6087AD5351D5

Q37173117-232822FE-EDA7-4A2F-AFE0-22E9C7BB1B92

P304

Q37173117-1B59530A-EF3C-479C-AB5F-D541141EF643

P31

Q37173117-CF0BFF66-F613-4E7C-9049-EF45F3E5869A

P356

Q37173117-A27E37A8-EA93-4A94-BE90-A9A18E0446B9

P407

Q37173117-EB45BC5F-4398-44FB-89C3-794836F19C8E

P433

Q37173117-0FC975F6-8820-43A7-8DE2-D48A46B149B1

P478

Q37173117-1A2B2819-7821-4F5B-AB8B-7F5E91E00F83

P50

Q37173117-08ACF6ED-DC8D-45C4-9614-E420AED8B885

Q37173117-45AB66F6-831C-46CD-B733-EED488D5085D

Q37173117-72CE5A2C-3024-4261-8D4D-4945BDF07F38

Q37173117-793AD428-FAA5-4B0A-BF59-A219E8A3F1A7

Q37173117-A9B24F32-2E7D-4AF5-A73B-5C1DFCB1C944

P577

Q37173117-B5A4F9B8-970A-4B22-BAD7-C35355B732A8

P5875

Q37173117-C75F2AA9-3A5B-4D37-8180-934C9FFEA8BF

P698

Q37173117-E10F05FE-7747-4566-AE90-5473EA6BCEEF

P921

Q37173117-AE503789-1F8F-4255-9EE3-DF0BF818AE6B

P932

Q37173117-9F845177-5C8A-4F42-ABCA-572ECCBC34FD

P356

PNAS.1309648110

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Anti-inflammatory and immunomo ...... ithout inhibition of elastase.

@en

P2093

Eli C Lewis

http://www.w3.org/2001/XMLSchema#string

Florian Laenger

http://www.w3.org/2001/XMLSchema#string

Galit Shahaf

http://www.w3.org/2001/XMLSchema#string

Hans Kreipe

http://www.w3.org/2001/XMLSchema#string

Jaewoo Hong

http://www.w3.org/2001/XMLSchema#string

Kwangwon Hong

http://www.w3.org/2001/XMLSchema#string

Lavinia Maegel

http://www.w3.org/2001/XMLSchema#string

Mariam Al-Omari

http://www.w3.org/2001/XMLSchema#string

Martina Dorsch

http://www.w3.org/2001/XMLSchema#string

Meike Müller

http://www.w3.org/2001/XMLSchema#string

P2860

α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8

Expanding the clinical indications for α(1)-antitrypsin therapy

Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1.

Amplification of mRNA from laser-microdissected single or clustered cells in formalin-fixed and paraffin-embedded tissues for application in quantitative real-time PCR.

Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice.

The discovery of α1-antitrypsin and its role in health and disease.

Intrinsic disorder modulates protein self-assembly and aggregation.

Therapeutic efficacy of α-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry.

Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency.

Alpha1-antitrypsin deficiency.

P304

15007-15012

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1309648110

http://www.w3.org/2001/XMLSchema#string

P407

P433

37

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P50

Sabina Janciauskiene

Charles A. Dinarello

P577

2013-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256101498

http://www.w3.org/2001/XMLSchema#string

P698

23975926

http://www.w3.org/2001/XMLSchema#string

P921

P932

3773761

http://www.w3.org/2001/XMLSchema#string